Do Cardiologists Do It Better?  by Nash, Ira S et al.
PERSPECTIVE
Do Cardiologists Do It Better?
IRA S. NASH, MD, FACC, DAVID B. NASH, MD, MBA,* VALENTIN FUSTER, MD, PHD, FACC
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Pressure to lower the cost of health care delivery has fostered
widespread efforts to limit patients’ access to specialists such as
cardiologists. However, there is concern that diminished specialist
involvement may lead to poorer patient outcomes for specific
clinical conditions. As part of a state-sponsored effort to improve
the quality of health care in Pennsylvania, the Pennsylvania
Health Care Cost Containment Council gathered clinical and
administrative data on all 40,684 hospital admissions for acute
myocardial infarction (AMI) in that state in 1993. They prepared
a detailed public report that included risk-adjusted in-hospital
mortality and length of hospital stay by physician group, by
hospital and by region. These data demonstrate that patients
cared for by cardiologists, as a group, had a lower risk-adjusted
mortality than patients cared for by either internists (risk ratio
1.26, 95% confidence interval 1.17 to 1.35) or family practitioners
(risk ratio 1.29, 95% confidence interval 1.18 to 1.40). The patients
of cardiologists also had a shorter length of stay than the other
two groups. These data suggest that there is enhanced value in the
care provided by cardiologists for patients with AMI and call into
question the growing trend toward reliance on generalists instead
of specialists.
(J Am Coll Cardiol 1997;29:475–8)
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The U.S. health care system is undergoing a dramatic trans-
formation, driven by the intense pressure to lower costs
brought to bear on providers by payors. However, there is
widespread recognition that low costs alone are no bargain and
that the critical issue in evaluating clinical services is not just
their cost but their value (1). That is, the important question is
not simply, How much does it cost?, but, rather, Is the
anticipated benefit worth the expenditure? Cost is a sufficient
measure only when comparing identical items or services
(commodities). Value incorporates the quality of those items
or the outcome of those services, or both. Unfortunately, costs
are much easier to measure than quality or outcomes, so our
ability to draw conclusions regarding the value of particular
medical practices remains limited.
One area where value has been difficult to determine is in
the provision of care by specialists as opposed to generalists.
Acting primarily on the belief that specialists provide costlier
care than generalists, many managed care organizations have
attempted to reduce their reliance on specialists (2). In closed
panel health maintenance organizations (HMOs), relatively
few specialists have been hired (3). In more open managed
care arrangements, such as preferred provider organizations
(PPOs), access to specialists is restricted by a variety of
administrative barriers and gatekeeper physician incentives
(4,5). The implications of such restrictions, were they to be
universally adopted, are profound (6) and raise important
questions about the appropriate national and regional provider
mix of generalists and specialists (7). Indeed, the shift away
from our current high rates of specialty care by managed care
organizations has spawned considerable debate about how to
increase the number of primary care providers relative to
specialists (8–11) but nearly universal agreement that such a
shift is desirable (12,13). It has also generated, in response,
efforts by specialists to convince the public of the importance
of continued access to their services. During the national
debate on health finance reform, for example, the American
College of Cardiology sponsored advertisements in leading
newspapers stating that “direct, unrestricted access to the heart
specialist of your choice could save your life” (The New York
Times, June 12, 1995).
All these questions—the relative need for generalist and
specialist services, the implications that this relative need has
on training programs and academic institutions and the value
of patient access to specialty services—would benefit from
more data on the relative quality and cost of care provided by
specialists and generalists for specific conditions (14). Some
data of this sort, with specific reference to cardiac care, are
presently available. In 1993, Borowsky et al. (15) reported that
patients cared for by cardiologists were significantly more
likely than patients cared for by noncardiologists to undergo
“clinically necessary” coronary angiography, defined by guide-
lines developed by a RAND Corporation/University of Cali-
fornia Los Angeles expert panel that included primary care
physicians, invasive and noninvasive cardiologists and cardio-
thoracic surgeons. Borowsky et al. did not attempt to detect
differences in patient outcomes on the basis of observed
differences in the use of coronary angiography.
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Similarly, Ayanian et al. (16) reported that cardiologists
were more likely than internists or family practitioners to
prescribe therapies of proven efficacy in the care of patients
with acute myocardial infarction (AMI). For example, 94.1%
of surveyed cardiologists reported that they were “very likely”
to prescribe a thrombolytic agent, whereas only 82% of
internists and 77.3% of family practitioners reported that they
would do the same (p , 0.001 for pairwise comparisons with
cardiologists). Once again, the study did not attempt to detect
differences in patient outcomes traceable to this and other
treatment disparities.
More recent studies also suggest that cardiologists provide
higher quality of care than noncardiologists for patients with
AMI on the basis of closer adherence to national treatment
guidelines.* In addition, Jollis et al. (17) reported that Medi-
care patients with AMI admitted by a cardiologist had a lower
risk-adjusted 1-year mortality than patients admitted by a
primary care physician. Finally, other data cast doubt on
whether limiting access to cardiologists saves money, irrespec-
tive of process of care quality measures.† The recently released
reports from the Pennsylvania Health Care Cost Containment
Council (PHC4) (18–20) offer a large-scale examination of the
differences in the outcomes of patients with AMI (not just the
process of care) and treatment costs based on attending
physician specialty.
Pennsylvania Health Care Cost
Containment Council
The PHC4 is a state agency chartered to “collect and
publish useful information about the charges and patient
outcomes for various medical and surgical procedures” (18).
Because of the mortality and prevalence of AMI, the PHC4
undertook an analysis of the statewide data collected on all
40,684 admissions for AMI to Pennsylvania hospitals that
occurred in calendar year 1993 (21). Hospitals in Pennsylvania
are responsible for supplying the PHC4 with detailed admin-
istratively derived, patient-specific information, including de-
mographics, resource (procedure) utilization, comorbidities,
measures of disease severity and the name of a single attending
physician. The PHC4 used these data to develop two separate
multivariate risk adjustment logistic regression models to
predict hospital mortality, after excluding 1,428 patients
(3.5%) for prespecified reasons. Exclusionary criteria included
patients treated at hospitals that closed after 1993 or provided
care for ,30 patients with AMI during the study period,
patients ,30 or .99 years old, patients who left against
medical advice, patients involved in two or more hospital
transfers and patients who met “clinical complexity” criteria
(major trauma, anoxic encephalopathy, metastatic cancer or
previous heart transplantation). One risk adjustment model
pertained to patients who were directly admitted to a hospital;
the other model predicted in-hospital deaths for patients who
were transferred from another acute care facility. The models
were then used to generate risk-adjusted mortality rates for
AMI by region, payor, hospital and physician group (although
not by individual physician). Another separate linear regres-
sion model was created to predict inpatient length of stay,
treating “transfer-in” status as a variable. One of us (D.B.N.)
served as the chairman of the Technical Advisory Group, a
standing committee responsible for overseeing the PHC4’s
methodology and analysis. A detailed multivolume report of
the methodology, statistical performance of the risk adjust-
ment models and the principal findings is publicly available
(22,23).
Principal Findings
Two findings of the study have important implications for
the generalist/specialist issue. First, the PHC4 found significant
differences in risk-adjusted mortality among the three groups
of physicians who, collectively, were identified as the attending
physician for nearly 95% of all AMI admissions (Table 1). The
adjusted inpatient mortality risk ratios, calculated from the
data in the PHC4 report, for treatment by a family practitioner
or an internist relative to a cardiologist, are both statistically
significantly different from 1. If all 12,960 patients who were
treated by internists had instead been treated by cardiologists,
application of the different risk-adjusted mortality rates sug-
gests that 285 fewer deaths would have been anticipated. Had
cardiologists cared for the 6,971 patients of the family medi-
cine physicians, the data suggest that there would have been
174 fewer inpatient fatalities.
The second finding of the PHC4 that has important impli-
*Wilson D, Soumerai SB, McLaughlin T, et al. Cardiologist and generalist
involvement in the care of acute MI—implications for quality [abstract]. Pre-
sented at the 13th Annual Meeting of the Association of Health Services
Research, Atlanta, Georgia, June 1996.
†Warner CD, Weintraub WS, Rask K, Saunders C. Does the gatekeeper
model of managed care affect access to specialists for patients with chest pain?
[abstract]. Presented at the 13th Annual Meeting of the Association of Health
Services Research, Atlanta, Georgia, June 1996.
Table 1. In-Hospital Mortality by Attending Physician Designation
Designation
No.
Treated
Actual
Mortality
[no. (%)]
Risk-
Adjusted
Mortality
Rate (%) RR (95% CI)
Cardiology 16,996 1,341 (7.9) 8.6 1.00
Internal medicine 12,960 1,555 (12.0) 10.8 1.26
(1.17–1.35)
Family medicine 6,971 772 (11.1) 11.1 1.29
(1.18–1.40)
CI 5 confidence interval; RR 5 risk ratio.
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
PHC4 5 Pennsylvania Health Care Cost Containment Council
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cations for the relative value of care provided by cardiologists
and other physicians is the mean inpatient length of stay by
attending specialty (Table 2). For each physician group, the
mean length of stay was predicted using the multivariate
regression model developed for that purpose. Fewer patients
were included in the length of stay analysis than in the
inpatient mortality analysis because deaths, transfers out and
patients with a length of stay .40 days were deliberately
excluded. Only patients treated by cardiologists, as a group,
had an actual mean length of stay statistically shorter than that
predicted by the model, whereas patients treated by internists
had an actual mean length of stay significantly longer than that
predicted by the model, and those treated by family practitio-
ners had a length of stay not distinguishable statistically from
that predicted by the model.
Discussion
The PHC4 acknowledged in its report that “choosing one
physician as the ‘attending’ was a difficult task” and that “the
methods used by hospitals in assigning [identifying] physician
were diverse” (23). Physicians were also identified by the
hospitals by specialty—cardiology, cardiothoracic surgery, in-
ternal medicine, family medicine or “other.” Finally, the PHC4
also contacted attending physicians directly so that they could
report their own professional identity. This process of physi-
cian specialty identification generated uncertainty concerning
the “real” identity of the “responsible” physician, both in terms
of actual name and specialty designation. For instance, it is
unclear whether a patient admitted by an internist and seen in
consultation by a cardiologist would be characterized as having
been cared for by the former or the latter, or even if such a
designation was made consistently within or among hospitals.
Furthermore, the process of physician identification did not
involve verification of credentials, so it is possible, for example,
that some physicians identified as cardiologists do not have
American Board of Internal Medicine certification as such.
These uncertainties have the effect of diminishing any true
differences in outcome by physician designation that might be
apparent were physicians identified by stricter, more consistent
criteria. Yet, even with this potential blurring of distinctions,
significant outcome differences exist among the physician
groupings.
Do cardiologists “do it better”—that is, provide higher
quality and less costly care for patients with AMI than inter-
nists and family practitioners? Although the data suggest that
they do, limitations of the PHC4 report should prompt some
caution. The lower mortality rates achieved by cardiologists
may be primarily a reflection of the relative number of patients
with AMI treated by each practitioner. Inpatient mortality is
dependent on events early in the hospital course, such as
treatment initiated by the emergency department staff, which
may occur before the involvement of the attending of record.
If such early treatment were linked in some way to patient
assignment, this could confound the analysis. In addition,
although inpatient mortality is certainly an important dimen-
sion of the quality of care, it is not the only appropriate
measure. The PHC4 report is silent on other potential quality
measures, such as patient satisfaction, functional status at
discharge, physician-directed modification of risk factors to
prevent another coronary event and late mortality. Likewise,
length of stay is, at best, a crude measure of the overall cost of
care provided. No physician-stratified data are available from
the PHC4 report on other important “drivers” of cost, such as
resource utilization (e.g., whether cardiologists order more
echocardiograms than other physicians for patients with AMI)
or referral for catheterization and revascularization proce-
dures. The differences in length of stay are small in absolute
terms and could potentially be overshadowed by some of these
other costs. Finally, the conclusions of the PHC4 would be
strengthened by repeating the analysis using attending physi-
cian designation as an independent variable and assessing
directly its impact on patient outcomes. Only further analysis
of these data, along with the examination of other, contempo-
rary, large data bases can address these issues.
These limitations, although important, do not negate the
principal findings that a comprehensive examination of all
hospital admissions of patients with AMI in the state of
Pennsylvania in 1993 found that cardiologists achieve a lower
mortality with a lower ratio of actual to predicted inpatient
length of stay than either internists or family practitioners. The
reasons why this is so are not clear. However, what is clear is
that more comparative data such as these, even down to the
physician level, will be demanded of physicians and hospitals in
the years ahead (24). The challenge we face is to collect (25)
and use (26) these data in a responsible way, for they may be
critically important in helping consumers, providers and payors
make well informed decisions about the appropriate level of
access to specialized cardiac care and, by extension, the
number of cardiologists needed to provide it.
We thank Ernest Sessa, Executive Director of the Pennsylvania Health Care
Cost Containment Council for his encouragement and Jayne Jones, also of the
Council, for technical support. The views expressed here are solely those of the
authors.
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